GlassScriptPhysician profile
Thomas A Alberico
NPI 1346650959
$3,381.42
in general payments reported to CMS, 2019-2025
10 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $21.86 · 2021: $92.15 · 2022: $2,188 · 2023: $189 · 2024: $28.22 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,261.38 | 2022-2025 | Penumbra System, Ruby Coil |
| Boston Scientific Corporation | $601.69 | 2019 | |
| Medtronic, INC. | $170.52 | 2023 | Osteocool Rf Ablation System |
| Inari Medical, INC. | $137.20 | 2019 | |
| Relievant Medsystems, INC. | $77.19 | 2021 | |
| Stryker Corporation | $47.54 | 2025 | Flowtriever |
| Canon Medical Systems USA, INC. | $30.46 | 2025 | Interventional Angiography System |
| Medtronic USA, INC. | $21.86 | 2020 | |
| Shockwave Medical, INC | $18.62 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Siemens Medical Solutions USA, INC. | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Alberico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.